U.S Physical Therapy Total Liabilities 2010-2024 | USPH

U.S Physical Therapy total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
U.S Physical Therapy Annual Total Liabilities
(Millions of US $)
2023 $520
2022 $541
2021 $452
2020 $317
2019 $319
2018 $226
2017 $213
2016 $163
2015 $131
2014 $77
2013 $73
2012 $37
2011 $42
2010 $24
2009 $19
U.S Physical Therapy Quarterly Total Liabilities
(Millions of US $)
2024-06-30 $538
2024-03-31 $536
2023-12-31 $520
2023-09-30 $517
2023-06-30 $510
2023-03-31 $549
2022-12-31 $541
2022-09-30 $481
2022-06-30 $488
2022-03-31 $462
2021-12-31 $452
2021-09-30 $339
2021-06-30 $338
2021-03-31 $321
2020-12-31 $317
2020-09-30 $310
2020-06-30 $328
2020-03-31 $401
2019-12-31 $319
2019-09-30 $328
2019-06-30 $326
2019-03-31 $302
2018-12-31 $226
2018-09-30 $242
2018-06-30 $228
2018-03-31 $209
2017-12-31 $213
2017-09-30 $211
2017-06-30 $221
2017-03-31 $195
2016-12-31 $163
2016-09-30 $91
2016-06-30 $99
2016-03-31 $102
2015-12-31 $131
2015-09-30 $90
2015-06-30 $86
2015-03-31 $81
2014-12-31 $77
2014-09-30 $85
2014-06-30 $76
2014-03-31 $74
2013-12-31 $73
2013-09-30 $33
2013-06-30 $35
2013-03-31 $37
2012-12-31 $37
2012-09-30 $34
2012-06-30 $38
2012-03-31 $39
2011-12-31 $42
2011-09-30 $42
2011-06-30 $32
2011-03-31 $33
2010-12-31 $24
2010-09-30 $20
2010-06-30 $21
2010-03-31 $29
2009-12-31 $19
2009-09-30 $22
2009-06-30 $27
2009-03-31 $31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.464B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.921B 12.66
Quest Diagnostics (DGX) United States $17.320B 17.55
DaVita (DVA) United States $12.060B 15.60
Encompass Health (EHC) United States $10.267B 24.21
Chemed (CHE) United States $8.277B 25.44
Elanco Animal Health (ELAN) United States $6.357B 14.29
RadNet (RDNT) United States $5.166B 122.54
Option Care Health (OPCH) United States $3.999B 18.95
Amedisys (AMED) United States $3.199B 22.78
Astrana Health (ASTH) United States $2.920B 41.31
LifeStance Health (LFST) United States $2.728B 0.00
Addus HomeCare (ADUS) United States $2.375B 27.86
Pennant (PNTG) United States $1.004B 46.00
Aveanna Healthcare Holdings (AVAH) United States $0.929B 0.00
Atai Life Sciences (ATAI) Germany $0.198B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00